269 filings
Page 5 of 14
8-K
5vfv1des3y4cdwl
18 Dec 19
Regulation FD Disclosure
5:27pm
8-K
i164dn
19 Nov 19
Regulation FD Disclosure
6:46am
8-K
af9ctv
6 Nov 19
TherapeuticsMD Announces Third Quarter 2019 Financial Results
4:08pm
8-K
0l15eazbplqs
29 Oct 19
Entry into a Material Definitive Agreement
8:52am
8-K
7q6qxmdtnng8i
23 Oct 19
TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results
5:25pm
8-K
n0nhdjw6w tmsv3
15 Oct 19
Regulation FD Disclosure
7:00am
8-K
s7n72sq1c6jqzpe4qztn
1 Oct 19
1 Investor Presentation October 2019 Building a Premier Women’s Health Portfolio
7:01am
8-K
d22ti8pulq2ap 6w
25 Sep 19
Regulation FD Disclosure
6:31am
8-K
fclwxtm4ah0 4m3lrzu
16 Sep 19
1 Investor Presentation September 2019 Building a Premier Women’s Health Portfolio
6:46am
8-K
z6wssj13q4yy005b
6 Aug 19
TherapeuticsMD Announces Second Quarter 2019 Financial Results
4:07pm
8-K
gxy4z1k iu
9 Jul 19
Regulation FD Disclosure
6:57am
8-K
ghw0fxk
21 Jun 19
Departure of Directors or Certain Officers
4:22pm
8-K
880 b29jgr7xrgau
10 Jun 19
Regulation FD Disclosure
2:28pm
8-K
bpkr0m7b
7 Jun 19
TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States
7:15am
8-K
lrrqe1sk zsagk43z
15 May 19
Regulation FD Disclosure
7:00am
8-K
9ozsjvh
6 May 19
TherapeuticsMD Announces First Quarter 2019 Financial Results
4:07pm
8-K
o9l1oi3
25 Apr 19
TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility
4:33pm
8-K
7cuz doy9d
17 Apr 19
TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners
4:08pm
8-K
qgo802u87 uslk
8 Apr 19
Regulation FD Disclosure
7:00am
8-K
apnlg6obrmn q6rsewog
12 Mar 19
Investor Presentation March 2019
7:00am